ArticleFood science & nutrition2024
Potential of cold plasma pretreatment for preserving biochemical attributes and ensuring the microbiological safety of saffron stigma.
Article in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Structural Remodeling, Redox Regulation, and Metabolic Responses in Cold Plasma Pretreatment-Assisted Drying of Foods: A Critical Review.Foods (Basel, Switzerland) · 2026Review
- Cold Plasma as a Promising Non-Thermal Strategy for Enhancing Food Safety: A Review of Microbial and Mycotoxin Decontamination.Molecules (Basel, Switzerland) · 2026Review
- Effect of Cold Plasma on the Microbial Safety and Physicochemical Properties of Functional Supplement Powder.Food science & nutrition · 2025Article
- Advances in Atmospheric Cold Plasma Technology for Plant-Based Food Safety, Functionality, and Quality Implications.Foods (Basel, Switzerland) · 2025Review
- The impact of gamma and electron beam irradiation sterilization technology on the pigments and phenolic components of saffron.Scientific reports · 2025Article
- Potential of cold plasma pretreatment for preserving biochemical attributes and ensuring the microbiological safety of saffron stigma.Food science & nutrition · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Saffron, similar to numerous other agricultural commodities, is susceptible to microbial contamination during cultivation and postharvest handling. Cold plasma treatment has emerged as an effective method for microbial inactivation while preserving food quality. The aim of this research was to preserve the color integrity and minimize the presence of microorganisms in dried saffron stigma by implementing cold plasma pre-treatment. Process parameters were optimized using the response surface method (RSM), considering the type of atmosphere (argon and air), plasma exposure time (1, 5, and 10 min), and plasma power (40, 70, and 100 W) as independent variables. The objectives were to maximize crocin content and minimize the total microbial load. The analysis of the response surface revealed that the argon atmosphere had a more significant impact on reducing microbial contamination than air, and an increase in plasma exposure time led to a decrease in microbial load. The maximum reduction in microbial load, by 0.9 logarithmic cycles compared to the control, was achieved with a 10-min treatment at 40 W power. Extended plasma exposure durations led to a minor reduction in the color, taste, aroma, and antioxidant properties of saffron stigma. Specifically, the color, taste, and aroma decreased by 0.5%, 0.5%, and 0.08%, respectively, with longer plasma exposure times. The antioxidant activity decreased by 0.64% with prolonged exposure time. However, the plasma-treated samples did not show any signs of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.